Abstract
Current stroke treatment guidelines exclude unknown onset stroke (UOS) patients from thrombolytic therapy even though several studies have reported significant treatment efficacy and safety. We performed a meta-analysis of relevant studies retrieved by systematic searches of the PubMed, Embase, and Cochrane databases up to December 31, 2013. Dichotomized modified Rankin Scale (mRS) scores 0–1 at 90 days, mRS 0–2 at 90 days, overall mortality, and symptomatic intracranial hemorrhage (sICH) incidence were collected as primary outcome measures. Fixed effects meta-analytical models were used, and between-study heterogeneity was assessed. Eleven studies encompassing 1,832 patients were included. In case–control studies of UOS patients, thrombolysis was associated with a significant increase in the proportion of patients with mRS scores of 0–1 (OR 2.37; 95 % CI 1.20–4.69; P = 0.013) and 0–2 (OR 2.03; 95 % CI 1.26–3.30; P = 0.004) without increased mortality or sICH incidence. In studies comparing thrombolysis-treated UOS to thrombolysis-treated known onset stroke, however, fewer UOS patients had mRS scores of 0–1 (OR 0.70; 95 % CI 0.51–0.97; P = 0.033) with no change in mortality, sICH incidence, or patients with mRS of 0–2. Subgroup analysis based on imaging criteria and time window of thrombolysis indicated that UOS patients treated within 3 h after first found abnormal and those with early ischemic changes restricted to <1/3 of the middle cerebral artery territory gained more benefit from thrombolysis treatment than the whole UOS population. Randomized controlled trials are warranted to confirm the efficacy of thrombolysis in this UOS subgroup.
Similar content being viewed by others
References
Mackay J, Mensah GA (2004) The atlas of heart disease and stroke. World Health Organization (WHO), Geneva
Jauch EC, Saver JL, Adams HP, Bruno JA, Connors JJ et al (2013) Guideline for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. doi:10.1161/STR.0b013e318284056a
Fink JN, Kumar S, Horkan C et al (2002) The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 33:988–993
Mackey J, Kleindorfer D, Sucharew H et al (2011) Population-based study of wake-up strokes. Neurology 76:1662–1667. doi:10.1212/WNL.0b013e318219fb30
Moradiya Y, Janjua N (2013) Presentation and outcomes of ‘wake-up strokes’ in a large randomized stroke trial: analysis of data from the International Stroke Trial. J Stroke Cerebrovasc Dis. 22:286–292. doi:10.1016/j.jstrokecerebrovasdis.2012.07.016
Silva GS, Lima FO, Camargo EC et al (2010) Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis. 29:336–342. doi:10.1159/000278929
Manawadu D, Bodla S, Keep J, Jarosz J, Kalra L (2013) An observational study of thrombolysis outcomes in wake-up ischemic stroke patients. Stroke 44:427–431. doi:10.1161/STROKEAHA.112.673145
Barreto AD, Martin-Schild S, Hallevi H et al (2009) Thrombolytic therapy for patients who wake-up with stroke. Stroke 40:827–832. doi:10.1161/STROKEAHA.108.528034
Ebinger M, Scheitz JF, Kufner A, Endres M, Fiebach JB, Nolte CH (2012) MRI-based intravenous thrombolysis in stroke patients with unknown time of symptom onset. Eur J Neurol 19:348–350. doi:10.1111/j.1468-1331.2011.03504.x
Thomalla G, Fiebach JB, Ostergaard L et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke 2013; 3.1210.1111/ijs.12011 [PubMed: 23490032]
Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M (2003) The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm
DerSimon R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Roveri L, La Gioia S, Ghidinelli C, Anzalone N, De Filippis C, Comi G (2013) Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke. J Stroke Cerebrovasc Dis. 22:703–708. doi:10.1016/j.jstrokecerebrovasdis.2011.10.003
Breuer L, Schellinger PD, Huttner HB et al (2010) Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience. Int J Stroke 5:68–73. doi:10.1111/j.1747-4949.2010.00410.x
Manawadu D, Bodla S, Jarosz J, Keep J, Kalra L (2013) A case–controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients. Stroke 44:2226–2231. doi:10.1161/STROKEAHA.111.000757
Bai Q, Zhao Z, Fu P et al (2013) Clinical outcomes of fast MRI-based trombolysis in wake-up strokes compared to superacute ischemic strokes within 12 hours. Neurol Res 35:492–497. doi:10.1179/1743132813Y.0000000208
Kim JT, Park MS, Nam TS et al (2011) Thrombolysis as a factor associated with favorable outcomes in patients with unclear-onset stroke. Eur J Neurol 18:988–994. doi:10.1111/j.1468-1331.2011.03351.x
Cho AH, Sohn SI, Han MK et al (2008) Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke:a preliminary report. Cerebrovasc Dis. 25:572–579. doi:10.1159/000132204
Aoki J, Kimura K, Shibazaki K, Sakamoto Y (2013) Negative fluid-attenuated inversion recovery-based intravenous thrombolysis using recombinant tissue plasminogen activator in acute stroke patients with unknown onset time. Cerebrovasc Dis Extra. 3:35–45. doi:10.1159/000348552
Cortijo E, García-Bermejo P, Calleja AI et al (2014) Intravenous thrombolysis in ischemic stroke with unknown onset using CT perfusion. Acta Neurol Scand 129:178–183. doi:10.1111/ane.12160
Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM (2001) Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 56:1015–1020
Michel P, Odier C, Rutgers M et al (2010) The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke 41:2491–2498. doi:10.1161/STROKEAHA.110.596189
Huisa BN, Raman R, Ernstrom K et al (2010) Alberta Stroke Program Early CT Score (ASPECTS) in patients with wake-up stroke. J Stroke Cerebrovasc Dis. 19:475–479. doi:10.1016/j.jstrokecerebrovasdis.2010.03.003
Kim BJ, Kim HJ, Lee DH et al (2014) Diffusion-weighted image and fluid-attenuated inversion recovery image mismatch: unclear-onset versus clear-onset stroke. Stroke 45:450–455. doi:10.1161/STROKEAHA.113.002830
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hu, Y.Z., Xu, Z.Q., Lu, X.Y. et al. Efficacy and safety of thrombolysis for stroke of unknown onset time: a meta-analysis. J Thromb Thrombolysis 38, 528–539 (2014). https://doi.org/10.1007/s11239-014-1116-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-014-1116-z